Echo- Stress during Edge-to-Edge Mitral Valve Repair Can Be Useful

Transcatheter edge-to-edge mitral valve repair with Mitraclip has become a valid strategy to treat mitral valve regurgitation (MR) when surgery is not viable. However, after discharge, residual MR (>moderate) can affect over 10% of patients, because of the use of anesthesia, which alters pre and post procedural measurements. In this context, eco-stress could become a useful tool to identify patients presenting residual MR.

El eco-stress durante el tratamiento borde a borde puede ser útil

The study included 39 patients with severe MR undergoing edge-to-edge with MitraClip. After procedure, patients were tested with eco-stress with dobutamine under general anesthesia.

Mean age was 76, 39% were men, 36% hypertensive, 26% diabetic, 21% had prior MI, 23% PCI, 15% CABG, 54% atrial fibrillation, most were in functional class II-IV and most had high NT ProBNP.

Most patients received one or two clips.

By the end of procedure, 30 patients presented mild and moderate mitral valve regurgitation. 

After eco-stress with dobutamine, 11 patients saw increased MR. 6 presented >moderate.MR.

Read also: EuroPCR 2023 | ACURATE Neo2: Results After 5 Years.

Test diagnostic performance was established at 100% sensitivity and 85% specificity in unselected patients. 

Conclusion

The use of eco-stress during edge-to-edge can predict increased MR. In addition, it could support decision making during procedure, even when considering additional clips, and potentially improve evolution. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Dobutamine stress echocardiography during transcatheter edge‐to‐edge mitral valve repair predicts residual mitral regurgitation.

Reference: Frank Meijerink, et al. Catheter Cardiovasc Interv. 2023;101:1128–1133.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

1-Year Outcomes of US TAVR Registry with 5th Generation Balloon Expandable Valves

The use of transcatheter aortic valve replacement (TAVR) has extended to younger patients with lower risk severe aortic stenosis (AS) and therefore the improvement...

EuroSMR Registry: Edge-to-Edge Mitral Treatment with 5-Year Outcomes

Cardiomyopathies and left atrial enlargement can lead to secondary mitral regurgitation (SMR). This condition is associated with ventricular dysfunction, causing heart failure, hospitalization, and...

TricValve Transcatheter Bicaval Valve System for Severe Tricuspid Insufficiency: Events at One Year

TricValve is the first bicaval valve system to obtain CE-Mark approval. This device heterotopic device eliminates tricuspid insufficiency reflux into the venous system, reducing...

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

1-Year Outcomes of US TAVR Registry with 5th Generation Balloon Expandable Valves

The use of transcatheter aortic valve replacement (TAVR) has extended to younger patients with lower risk severe aortic stenosis (AS) and therefore the improvement...

EuroSMR Registry: Edge-to-Edge Mitral Treatment with 5-Year Outcomes

Cardiomyopathies and left atrial enlargement can lead to secondary mitral regurgitation (SMR). This condition is associated with ventricular dysfunction, causing heart failure, hospitalization, and...

TricValve Transcatheter Bicaval Valve System for Severe Tricuspid Insufficiency: Events at One Year

TricValve is the first bicaval valve system to obtain CE-Mark approval. This device heterotopic device eliminates tricuspid insufficiency reflux into the venous system, reducing...